Events, News, Presentations
65th American Society of Hematology Annual Meeting and Exposition – Poster Anti-leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-α (FR-α)-targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBFA2T3::GLIS2 AML ...
Events, News, Presentations, Press Releases
Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit SOUTH SAN FRANCISCO, Calif., December 4, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...
Events, News, Presentations
Piper Sandler 35th Annual Healthcare Conference – Presentation...
Events, News, Presentations, Press Releases
Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023 – Luvelta demonstrated encouraging preliminary anti-tumor activity (29% response rate) in late-stage...
Events, News, Presentations
14th Annual World ADC Conference – Presentations and Poster Development of Next Generation ADCs Using Novel Expression Platforms & Precise ConjugationPresenter: Gang Yin Presentation Discovery of Novel Linker Payloads for Site-Specific ADCs with Improved Efficacy...
Events, News, Presentations, Press Releases
Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference SOUTH SAN FRANCISCO, Calif., October 16, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company...